genome scans and meta-analyses that are well-powered to evaluate rarer variants with modest effects are completed, we believe that imputation will become an increasingly important primary analysis and there are now examples of confirmed disease susceptibility loci that would have been missed without genotype imputation [Li et al., 2009b].
